F

Freenome Tech Stack

Blood-based cancer screening platform using multiomics and machine learning

Biotechnology Research Brisbane, California 201–500 employees Founded 2014 Privately Held

Freenome develops early-stage cancer detection tests from blood samples, combining genomic sequencing (Illumina), cloud compute (Azure, GCP, AWS EMR), and machine learning pipelines. The tech stack reflects a biotech-grade research operation: Veeva Vault for regulated workflows, Epic for healthcare integration, and emerging distributed deep learning infrastructure. Active hiring leans research-heavy (10 roles) with targeted additions in engineering and sales, while clinical adoption and reimbursement remain the stated operational bottlenecks—typical for diagnostic companies transitioning from lab validation to commercial deployment.

Tech Stack 34 technologies

Core StackNetSuite Jira Pulumi Kubernetes Python Epic Systems Palo Alto Networks Prisma Java Docker MySQL Salesforce HubSpot ZoomInfo Veeva Vault Illumina Azure Kubernetes Service Windows Azure Entra ID Freshservice ManageEngine Jamf Microsoft Office Google Workspace GCP VMware vSphere Juniper Networks Panorama Azure Excel+1 more

AdoptingAWS EMR

What Freenome Is Building

◆Challenges

Clinical adoption
Adoption of screening in health systems
Securing reimbursement for diagnostics
Global standard network infrastructure
Massive-scale genomic data challenges
Distributed dl pipeline optimization
Hardware utilization optimization
Training gaps in commercial team
Regulatory compliance in training
Driving efficiencies in accounting close

▲Active Projects

Implement emr and ux tools
Test ordering system
Dna assay development
Ngs method development
Digital marketing strategy development
It infrastructure change implementation
Implementation of financial systems
Early blood-based detection tests for cancer
Distributed dl pipeline infrastructure
Research platform improvement

Hiring Activity

Steady40 roles · 15 in 30d

Department

Research

10

Engineering

7

Sales

5

Healthcare

4

Product

4

Finance

3

Marketing

3

Ops

2

Seniority

Senior

18

Mid

10

Director

4

VP

3

Junior

2

Manager

2

Staff

2

Notable leadership hires: Finance Director

Company intelligence

Find more companies like Freenome by tech stack, pain points and active projects

Get started free

About Freenome

Freenome is a biotech company founded in 2014 developing next-generation blood tests to detect early-stage colorectal cancer and advanced adenomas. The company operates 201–500 employees across research, engineering, healthcare operations, and commercial functions, headquartered in Brisbane, California. The core technology platform combines genomic analysis (multiomics), machine learning, and cloud infrastructure to identify cancer biomarkers in blood. The product roadmap includes test ordering systems, assay development, and next-generation sequencing methods. The company has raised over $1.1 billion from institutional investors including Roche Venture Fund, Novartis, RA Capital, and Perceptive Advisors.

HeadquartersBrisbane, California

Company Size201–500 employees

Founded2014

Hiring MarketsUnited States

Frequently Asked Questions

What technology does Freenome use for cancer detection?

Freenome's platform combines multiomics analysis, machine learning, and next-generation sequencing. The stack includes Illumina sequencing instruments, Azure and GCP cloud compute, Python for analytics, and Kubernetes for pipeline orchestration.

What are Freenome's main operational challenges?

Clinical adoption and securing reimbursement for diagnostics are top strategic hurdles. Technical challenges include distributed deep learning pipeline optimization, genomic data scale, and healthcare system integration via Epic.